Ingevity Corporation
NGVT | NYSE
$75.15
+$0.83 (+1.12%)
Nov 2, 2026, 12:16 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 1.17B | 1.41B | 1.69B | 1.67B | 1.39B | 1.22B |
Cost of Revenue | 706.1M | 951.7M | 1.22B | 1.1B | 878.7M | 750.6M |
Gross Profit | 461.5M | 454.7M | 471.9M | 570.1M | 512.8M | 465.5M |
Operating Income | 261.9M | 259.9M | 256.4M | 341M | 307.2M | n/a |
Interest Income | 4.4M | 6.9M | 6.3M | 5.8M | 4M | 4.9M |
Pretax Income | -142.1M | -535.6M | -10.1M | 269.6M | 162.8M | 235.1M |
Net Income | -167.1M | -430.3M | -5.4M | 211.6M | 118.1M | 181.4M |
Selling & General & Admin | 171.2M | 166.7M | 183.7M | 198.8M | 179.3M | 149.4M |
Research & Development | 28.4M | 28.1M | 31.8M | 30.3M | 26.3M | 22.6M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | 293.5M |
Operating Expenses | 199.6M | 194.8M | 215.5M | 229.1M | 205.6M | 465.5M |
Interest Expense | 77.1M | 97.8M | 93.3M | 61.8M | 51.7M | 47.1M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 905.7M | 1.15B | 1.44B | 1.33B | 1.08B | 1.22B |
Income Tax Expense | 8.2M | -105.3M | -4.7M | 58M | 44.7M | 53.7M |
Shares Outstanding (Basic) | 36.2M | 36.32M | 36.5M | 38.47M | 39.8M | 41.3M |
Shares Outstanding (Diluted) | 36.2M | 36.32M | 36.5M | 38.47M | 40.06M | 41.55M |
EPS (Basic) | -4.61 | -11.85 | -0.15 | 5.50 | 2.97 | 4.39 |
EPS (Diluted) | -4.61 | -11.85 | -0.15 | 5.50 | 2.95 | 4.37 |
EBITDA | 37.4M | -329.5M | 206M | 440.2M | 324.4M | 382.4M |
EBIT | -69M | -437.8M | 83.2M | 331.4M | 214.5M | 282.2M |
Depreciation & Amortization | 106.4M | 108.3M | 122.8M | 108.8M | 109.9M | 100.2M |
Add to Watchlist
Select watchlists to add or remove NGVT